The Immunogenic Potential of Biosimilars: Should Health Care Providers Be Concerned?

Immunogenicity is an important consideration for all biologics, not just for biosimilars, noted Steven Lucio, Senior Director, Clinical Solutions and Pharmacy Program Development at Novation.

Immunogenicity is an important consideration for all biologics, not just for biosimilars, noted Steven Lucio, Senior Director, Clinical Solutions and Pharmacy Program Development at Novation.

This video was shot at the 2013 Academy of Managed Care Pharmacy in San Antonio, Texas.